<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005638.pub3" GROUP_ID="MENSTR" ID="976705060618312912" MERGED_FROM="" MODIFIED="2014-08-06 04:08:18 +0100" MODIFIED_BY="Helen Nagels" NOTES="&lt;p&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2014-08-06 15:07:02 +1200" NOTES_MODIFIED_BY="Helen E Nagels" REVIEW_NO="LJOS1131" REVMAN_SUB_VERSION="5.3.3 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2014-08-06 04:08:18 +0100" MODIFIED_BY="Helen Nagels">
<TITLE>Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women</TITLE>
<CONTACT MODIFIED="2014-08-06 04:08:18 +0100" MODIFIED_BY="Helen Nagels"><PERSON ID="4DCDAA5582E26AA2000C5DBB3A925A73" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Leonardo J</FIRST_NAME><LAST_NAME>Orozco</LAST_NAME><POSITION>Assistant physician</POSITION><EMAIL_1>lorozco@ihcai.org</EMAIL_1><EMAIL_2>lorozco@ihcai.org</EMAIL_2><ADDRESS><DEPARTMENT>OBGYN  Women's Hospital San José, Costa Rica</DEPARTMENT><ORGANISATION>Caja Costarricense Seguro Social (CCSS) &amp; Central American Cochrane Center</ORGANISATION><ADDRESS_1>Bo Carit</ADDRESS_1><CITY>San José</CITY><ZIP>11619-1000</ZIP><REGION>San Jose</REGION><COUNTRY CODE="CR">Costa Rica</COUNTRY><PHONE_1>+506-87350485</PHONE_1><FAX_1>+506 2255 0465</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-08-06 04:08:18 +0100" MODIFIED_BY="Helen Nagels"><PERSON ID="4DCDAA5582E26AA2000C5DBB3A925A73" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Leonardo J</FIRST_NAME><LAST_NAME>Orozco</LAST_NAME><POSITION>Assistant physician</POSITION><EMAIL_1>lorozco@ihcai.org</EMAIL_1><EMAIL_2>lorozco@ihcai.org</EMAIL_2><ADDRESS><DEPARTMENT>OBGYN  Women's Hospital San José, Costa Rica</DEPARTMENT><ORGANISATION>Caja Costarricense Seguro Social (CCSS) &amp; Central American Cochrane Center</ORGANISATION><ADDRESS_1>Bo Carit</ADDRESS_1><CITY>San José</CITY><ZIP>11619-1000</ZIP><REGION>San Jose</REGION><COUNTRY CODE="CR">Costa Rica</COUNTRY><PHONE_1>+506-87350485</PHONE_1><FAX_1>+506 2255 0465</FAX_1></ADDRESS></PERSON><PERSON ID="19336" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Mario</FIRST_NAME><LAST_NAME>Tristan</LAST_NAME><POSITION>Director-General &amp; CEO</POSITION><EMAIL_1>mtristan@ihcai.org</EMAIL_1><URL>www.ihcai.org- www. cochrane.ihcai.org</URL><MOBILE_PHONE>50687045380</MOBILE_PHONE><ADDRESS><DEPARTMENT>Board of Directors</DEPARTMENT><ORGANISATION>International Health Central American Institute</ORGANISATION><ADDRESS_1>Av. 7 Streets 35 and 37 N 3530</ADDRESS_1><ADDRESS_2>P.O. Box 1677-2100- IHCAI FOUNDATION</ADDRESS_2><CITY>San José</CITY><ZIP>2100</ZIP><REGION>San Jose</REGION><COUNTRY CODE="CR">Costa Rica</COUNTRY><PHONE_1>+506 22276564</PHONE_1><PHONE_2>+506 22346354</PHONE_2><FAX_1>+506 22263047</FAX_1></ADDRESS></PERSON><PERSON ID="z1401172023052636809916226272281" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Maria</FIRST_NAME><MIDDLE_INITIALS>MT</MIDDLE_INITIALS><LAST_NAME>Vreugdenhil</LAST_NAME><POSITION>Researcher</POSITION><EMAIL_1>mvreugdenhil@ihcai.org</EMAIL_1><EMAIL_2>mvreugdenhil@ihcai.org</EMAIL_2><MOBILE_PHONE>50685581461</MOBILE_PHONE><ADDRESS><ORGANISATION>IHCAI Foundation</ORGANISATION><ADDRESS_1>Av. 7 Streets 35 and 37 N 3530</ADDRESS_1><CITY>San Jose</CITY><ZIP>11101</ZIP><REGION>San Jose</REGION><COUNTRY CODE="CR">Costa Rica</COUNTRY><PHONE_1>50626411245</PHONE_1><FAX_1>50622346354</FAX_1></ADDRESS></PERSON><PERSON ID="18609" ROLE="AUTHOR"><FIRST_NAME>Arturo</FIRST_NAME><LAST_NAME>Salazar</LAST_NAME><POSITION>Internal Medicine/Pediatrics</POSITION><EMAIL_1>arturosalazarq@gmail.com</EMAIL_1><EMAIL_2>esalazar@ihcai.org</EMAIL_2><MOBILE_PHONE>+1(360)2244090</MOBILE_PHONE><ADDRESS><DEPARTMENT>PeaceHealth Hospital Medicine</DEPARTMENT><ORGANISATION>PeaceHealth</ORGANISATION><ADDRESS_1>3955 University St</ADDRESS_1><CITY>Eugene</CITY><ZIP>97405</ZIP><REGION>Oregon</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1(360)224-4090</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-07-24 14:28:53 +1200" MODIFIED_BY="Helen E Nagels">
<UP_TO_DATE>
<DATE DAY="31" MONTH="1" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="1" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="7" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="7" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-08-06 15:07:02 +1200" MODIFIED_BY="Helen E Nagels">
<WHATS_NEW_ENTRY EVENT="STABLE" MODIFIED="2014-08-06 15:07:02 +1200" MODIFIED_BY="Helen E Nagels">
<DATE DAY="6" MONTH="8" YEAR="2014"/>
<DESCRIPTION>
<P>New trials are not anticipated. This review will not be updated unless new evidence is published. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2014-08-06 15:04:00 +1200" MODIFIED_BY="Helen E Nagels">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-08-06 15:04:00 +1200" MODIFIED_BY="Helen E Nagels">
<DATE DAY="8" MONTH="5" YEAR="2014"/>
<DESCRIPTION>
<P>We excluded one previously included observational study (<LINK REF="STD-Aziz-2005" TYPE="STUDY">Aziz 2005</LINK>) and revised the methods, results and discussion sections.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-08-06 15:03:57 +1200" MODIFIED_BY="Helen E Nagels">
<DATE DAY="8" MONTH="5" YEAR="2014"/>
<DESCRIPTION>
<P>We have updated this review. Only one eligible RCT was identified but no data are yet available from this study.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-05-08 12:35:10 +1200" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="11" YEAR="2012"/>
<DESCRIPTION>
<P>Review full update </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-05-08 12:35:06 +1200" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="9" YEAR="2012"/>
<DESCRIPTION>
<P>New search. Updated methods .</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="13" MONTH="2" YEAR="2008"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Central American Branch of the Iberoamerican Cochrane Network</NAME>
<COUNTRY CODE="CR">Costa Rica</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>International Health Central American Institute (IHCAI Foundation)</NAME>
<COUNTRY CODE="CR">Costa Rica</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-07-24 14:51:40 +1200" MODIFIED_BY="Helen E Nagels">
<SUMMARY MODIFIED="2014-07-05 17:11:06 +1200" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2014-05-08 15:11:10 +1200" MODIFIED_BY="jane clarke">Hysterectomy versus hysterectomy plus ovary removal for premenopausal women</TITLE>
<SUMMARY_BODY MODIFIED="2014-07-05 17:11:06 +1200" MODIFIED_BY="[Empty name]">
<P>
<B>Review question:</B> Cochrane authors reviewed the evidence on the risks and benefits of the removal or conservation of ovaries at the time of hysterectomy for benign gynaecological disease in premenopausal women.</P>
<P>
<B>Background:</B> removing the ovaries at the time of hysterectomy could potentially reduce the risk of ovarian cancer and the need for future gynaecological procedures. However, premenopausal women who have had their ovaries removed have also been reported to have an increased risk of cardiovascular disease and other complications due to early menopause. It is not clear yet whether premenopausal women should be advised to have their ovaries removed or conserved at the time of hysterectomy.</P>
<P>
<B>Study characteristics: </B>studies were sought up to January 2014. No randomised studies were available that compared hysterectomy without removal of the ovaries versus hysterectomy plus removal of the ovaries.</P>
<P>
<B>Key results:</B> because of the lack of appropriate studies this review does not provide evidence to support removal or conservation of the ovaries at the time of hysterectomy in premenopausal women. Therefore, until evidence is available prophylactic removal of the ovaries should be regarded with caution.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-07-24 14:47:17 +1200" MODIFIED_BY="Helen E Nagels">
<ABS_BACKGROUND MODIFIED="2014-07-24 14:47:17 +1200" MODIFIED_BY="Helen E Nagels">
<P>Prophylactic oophorectomy alongside hysterectomy in premenopausal women is a common procedure. The decision to remove or conserve the ovaries is often based on the perceived risk for ovarian cancer and the need for additional gynaecological surgical interventions, and is weighed against the perceived risk of negative health effects caused by surgically induced menopause. The evidence needed to recommend either prophylactic bilateral oophorectomy or conservation of ovaries at the time of hysterectomy in premenopausal women is<B> </B>limited. This is an update of the original version of this systematic review published in 2008.<BR/>
</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2014-06-10 17:34:54 +1200" MODIFIED_BY="[Empty name]">
<P>To compare hysterectomy alone versus hysterectomy plus bilateral oophorectomy in women with benign gynaecological conditions, with respect to rates of mortality or subsequent gynaecological surgical interventions.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-07-05 17:06:25 +1200" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Menstrual Disorders and Subfertility Group Trials Register (December 2005 to January 2014) and the following electronic databases: CENTRAL (<I>The Cochrane Library </I>2013, Issue 12), MEDLINE (January 1966 to January 2014), EMBASE (January 1985 to January 2014), and PsycINFO (1806 to January 2014).<BR/>
</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2014-05-27 13:36:56 +1200" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs) of hysterectomy alone versus hysterectomy with bilateral oophorectomy in premenopausal women with benign gynaecological conditions were eligible. Any surgical approach could be used.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-04-11 08:32:33 +1200" MODIFIED_BY="[Empty name]">
<P>Three review authors independently assessed trials for inclusion. Study authors were contacted if information was unclear.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-07-05 17:07:34 +1200" MODIFIED_BY="[Empty name]">
<P>Only one RCT comparing the benefits and risks of hysterectomy with or without oophorectomy was identified. The results of this pilot RCT have not been published and we have not been able to obtain the results. Therefore, no data could be included in this review.<BR/>
</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-07-05 17:07:43 +1200" MODIFIED_BY="[Empty name]">
<P>The conclusions of this review are limited by a lack of RCTs. Although no evidence is available from RCTs, there is growing evidence from observational studies that surgical menopause may impact negatively on cardiovascular health and all cause mortality.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-07-24 14:48:26 +1200" MODIFIED_BY="Helen E Nagels">
<BACKGROUND MODIFIED="2014-07-05 17:39:38 +1200" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<CONDITION MODIFIED="2014-07-05 17:30:50 +1200" MODIFIED_BY="[Empty name]">
<P>The ovaries are complex endocrine organs that produce androgens and estrogens. They are involved in many metabolic processes such as bone and lipid metabolism. Androgen and estrogen levels decrease around the time of menopause (<LINK REF="REF-ACOG-2008" TYPE="REFERENCE">ACOG 2008</LINK>). Significant amounts of testosterone and androstenedione continue to be produced by the ovaries after menopause, and these androgens are converted to estrogen in adipose, muscle and other peripheral tissues (<LINK REF="REF-Judd-1974" TYPE="REFERENCE">Judd 1974</LINK>). Because of continuing ovarian function after menopause, the removal of the ovaries in premenopausal women may have clinically significant consequences (<LINK REF="REF-ACOG-2008" TYPE="REFERENCE">ACOG 2008</LINK>).</P>
<P>The most important reason to recommend prophylactic oophorectomy at the time of hysterectomy for benign disease is to decrease the risk of ovarian cancer (<LINK REF="REF-ACOG-2008" TYPE="REFERENCE">ACOG 2008</LINK>), which may be of importance because the overall five-year survival rate of ovarian cancer is relatively low, 44% in the USA (<LINK REF="REF-SEER-2013" TYPE="REFERENCE">SEER 2013</LINK>). However, ovarian cancer is rather rare with a lifetime risk of 1.4% in the USA between 2006 and 2010 (<LINK REF="REF-SEER-2013" TYPE="REFERENCE">SEER 2013</LINK>). Therefore, the reduction in risk of ovarian cancer due to prophylactic oophorectomy at the time of hysterectomy is likely to be low. Parker et al found, in an observational study carried out in the USA, a risk reduction for ovarian cancer due to prophylactic oophorectomy of around 4% and estimated that 220 oophorectomies would need to be performed to prevent one case of ovarian cancer (<LINK REF="REF-Parker-2009" TYPE="REFERENCE">Parker 2009</LINK>).</P>
<P>Women with an inherited mutation of the BRCA1 or BRCA2 genes are much more at risk of developing ovarian cancer; cumulative risks of 59% and 16.5% for BRCA1 and BRCA2 carriers, respectively, by the age of 70 years have been reported (<LINK REF="REF-Mavaddat-2013" TYPE="REFERENCE">Mavaddat 2013</LINK>). Therefore, the risk reduction of ovarian cancer due to prophylactic oophorectomy is likely to be much higher in these women than in the general population. Rebbeck et al used the data from an observational study to estimate a risk reduction of around 85% in BRCA carriers after prophylactic oophorectomy (<LINK REF="REF-Rebbeck-2002" TYPE="REFERENCE">Rebbeck 2002</LINK>). The American College of Obstetricians and Gynecologists (ACOG) recommends prophylactic oophorectomy in BRCA carriers, advice based on limited evidence (<LINK REF="REF-ACOG-2008" TYPE="REFERENCE">ACOG 2008</LINK>).</P>
<P>Another reason to consider prophylactic oophorectomy at the time of hysterectomy is to avoid gynaecological surgical interventions in the future. Zalel et al concluded that women with prior hysterectomy with ovarian preservation are prone to subsequent pelvic lesions such as benign ovarian tumours (for example cyst adenoma, peri-ovarian cysts) (<LINK REF="REF-Zalel-1997" TYPE="REFERENCE">Zalel 1997</LINK>). Casiano et al found in a cohort study of women who had undergone hysterectomy with conservation of the ovaries for benign disease an incidence of subsequent oophorectomy of 9.2% at 30-year follow-up, which was only 1.9 % higher than the incidence of oophorectomy in women with intact reproductive organs (<LINK REF="REF-Casiano-2013" TYPE="REFERENCE">Casiano 2013</LINK>). The ACOG recommends, based on consensus and expert opinion, that consideration be given to the higher risk of re-operation after hysterectomy without oophorectomy among women with endometriosis, pelvic inflammatory disease and chronic pain in the decision to remove or retain the ovaries (<LINK REF="REF-ACOG-2008" TYPE="REFERENCE">ACOG 2008</LINK>).</P>
<P>The benefits of prophylactic oophorectomy in premenopausal women have to be weighed against the risk associated with surgically induced menopause. Rocca et al found in a population-based cohort study that prophylactic bilateral oophorectomy before the age of 45 years was associated with an increase in all cause mortality (<LINK REF="REF-Rocca-2006" TYPE="REFERENCE">Rocca 2006</LINK>). Other prospective cohort studies with follow-up periods of more than 20 years have demonstrated increased risks of cardiovascular disease and cardiovascular mortality (<LINK REF="REF-Parker-2009" TYPE="REFERENCE">Parker 2009</LINK>; <LINK REF="REF-Rivera-2009" TYPE="REFERENCE">Rivera 2009</LINK>). Rocca et al found in an observational study an increased risk of cognitive impairment or dementia after oophorectomy in premenopausal women (<LINK REF="REF-Rocca-2007" TYPE="REFERENCE">Rocca 2007</LINK>). Also, higher risks of osteoporosis and bone fracture have been described after early menopause (<LINK REF="REF-Svejme-2012" TYPE="REFERENCE">Svejme 2012</LINK>).</P>
<P>Some of the harms caused by early menopause may be treated with hormonal therapy (HT). A Cochrane systematic review on the chronic use of HT in menopausal women found that bone fractures could be prevented after the use of HT over four or five years <U>(</U>
<LINK REF="REF-Marjoribanks-2012" TYPE="REFERENCE">Marjoribanks 2012</LINK>). However, this same review also demonstrated an increased risk of venous thromboembolism, stroke and gallbladder disease after long term use of estrogen. There was no evidence that HT prevents dementia. There were insufficient data to assess the risk of long term HT use in perimenopausal women or postmenopausal women younger than 50 years of age (<LINK REF="REF-Marjoribanks-2012" TYPE="REFERENCE">Marjoribanks 2012</LINK>). The findings of this systematic review were confirmed by a recent update of a Cochrane review that found that the use of HT does not prevent cardiovascular disease in postmenopausal women, and that HT increases the risk for stroke and venous thromboembolism. The authors of this review suggest that HT should be used with caution in postmenopausal women who have risk factors for cardiovascular disease (<LINK REF="REF-Main-2013" TYPE="REFERENCE">Main 2013</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2014-07-05 17:38:01 +1200" MODIFIED_BY="[Empty name]">
<P>Hysterectomy is the surgical removal of the uterus and there are three main surgical approaches: abdominal, vaginal and laparoscopic (<LINK REF="REF-Johnson-2005" TYPE="REFERENCE">Johnson 2005</LINK>). The approach used is the scope of another review (<LINK REF="REF-Johnson-2005" TYPE="REFERENCE">Johnson 2005</LINK>) and, therefore, is not the focus of this review. The ovaries can be removed or conserved regardless of the surgical approach. Hysterectomy is a rather common procedure in developed countries however with varying rates across individual countries, from 55 per 10,000 women of all ages in North America (<LINK REF="REF-CDC-2006" TYPE="REFERENCE">CDC 2006</LINK>), 28 per 10,000 in Britain, to 10 per 10,000 in Denmark (<LINK REF="REF-Guptaa-2006" TYPE="REFERENCE">Guptaa 2006</LINK>). This variation across countries has not yet been explained.</P>
<P>Oophorectomy is the surgical removal of the ovaries. The term prophylactic oophorectomy implies that the ovaries are normal at the time of their surgical removal. The procedure is performed with the intention of future benefit, such as prevention of ovarian cancer, alleviation of symptoms related to retained ovaries, or reduction of pelvic pain associated with peri-ovarian adhesions (<LINK REF="REF-ACOG-2008" TYPE="REFERENCE">ACOG 2008</LINK>). Prophylactic oophorectomy at the time of hysterectomy is common in the USA. In an analysis of a large database representing about 15% of all hospital admissions in the USA, 46.4% of women who had undergone a hysterectomy in the period 2000 to 2010 had had a bilateral oophorectomy at the time of the hysterectomy (<LINK REF="REF-Perera-2013" TYPE="REFERENCE">Perera 2013</LINK>). The ACOG recommendation for oophorectomy in premenopausal women without an increased genetic risk of ovarian cancer, based on consensus and expert opinion, is to strongly consider retaining the ovaries, whereas in postmenopausal women oophorectomy should be considered at the time of hysterectomy (<LINK REF="REF-ACOG-2008" TYPE="REFERENCE">ACOG 2008</LINK>). Predominant practice reflects the principle that prophylactic oophorectomy in women at low risk for ovarian cancer should be avoided under age 40 years, routinely performed over age 55 years, and individualized in the interval between 40 and 55 years (<LINK REF="REF-Olive-2005" TYPE="REFERENCE">Olive 2005</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2014-07-05 17:38:51 +1200" MODIFIED_BY="[Empty name]">
<P>The decision whether or not to perform a prophylactic bilateral oophorectomy in premenopausal women with benign gynaecological conditions requiring a hysterectomy is complex. The possible benefits, prevention of ovarian cancer and future gynaecological surgery, have to be weighed against the potential harm caused by surgically induced menopause.</P>
</THEORY>
<IMPORTANCE MODIFIED="2014-07-05 17:39:38 +1200" MODIFIED_BY="[Empty name]">
<P>This review attempts to establish the consequences of performing or not performing an oophorectomy at the time of hysterectomy for non-cancerous conditions in premenopausal women. To date, most of the practices are based on observational studies, consensus and expert opinion (<LINK REF="REF-ACOG-2008" TYPE="REFERENCE">ACOG 2008</LINK>), but the best approach regarding prophylactic oophorectomy remains uncertain. It is essential that both clinicians and women have access to reliable evidence to support their decision to remove or retain the ovaries at the time of hysterectomy.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2014-07-05 17:40:37 +1200" MODIFIED_BY="[Empty name]">
<P>To compare hysterectomy alone versus hysterectomy plus bilateral oophorectomy in women with benign gynaecological conditions, with respect to rates of mortality or subsequent gynaecological surgical interventions.</P>
</OBJECTIVES>
<METHODS MODIFIED="2014-07-24 14:48:26 +1200" MODIFIED_BY="Helen E Nagels">
<SELECTION_CRITERIA MODIFIED="2014-07-24 14:47:38 +1200" MODIFIED_BY="Helen E Nagels">
<CRIT_STUDIES MODIFIED="2014-07-05 17:40:56 +1200" MODIFIED_BY="[Empty name]">
<P>Published and unpublished randomised controlled trials (RCTs) were eligible for inclusion. We excluded non-randomised studies (for example studies with evidence of inadequate sequence generation such as alternate days, patient numbers) as they are associated with a high risk of bias. Crossover trials could not be included because they are not valid in the context of oophorectomy.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2014-07-05 17:41:53 +1200" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">Inclusion criteria </HEADING>
<P>Premenopausal women undergoing hysterectomy for benign gynaecological disease.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Exclusion criteria</HEADING>
<P>Women with gynaecological cancer or postmenopausal women as defined by primary study authors.</P>
</SUBSECTION>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2014-07-05 17:42:11 +1200" MODIFIED_BY="[Empty name]">
<P>Any surgical approach for hysterectomy without oophorectomy versus any surgical approach for hysterectomy with bilateral oophorectomy. We excluded any type of hysterectomy plus unilateral oophorectomy.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-07-24 14:47:38 +1200" MODIFIED_BY="Helen E Nagels">
<P>We selected the outcome measures for this review on the basis of their clinical significance.</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2014-07-05 17:43:11 +1200" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="6">(1) Mortality </HEADING>
<UL>
<LI>ovarian cancer</LI>
<LI>breast cancer</LI>
<LI>colon cancer</LI>
<LI>myocardial infarction</LI>
<LI>stroke</LI>
<LI>thromboembolism</LI>
<LI>all cause</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">(2) Future gynaecological surgical interventions </HEADING>
<UL>
<LI>unilateral or bilateral oophorectomy</LI>
<LI>any type of pelvic or gynaecological surgery</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2014-07-24 14:47:38 +1200" MODIFIED_BY="Helen E Nagels">
<SUBSECTION>
<HEADING LEVEL="6">(1) <I>Q</I>uality of life as defined by trial authors</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">(2) Patient satisfaction</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">(3) Adverse events</HEADING>
<UL>
<LI>ovarian neoplasia</LI>
<LI>pathological bone fractures as defined by trial authors</LI>
<LI>return of endometriosis</LI>
<LI>pelvic or abdominal pain</LI>
<LI>pelvic floor condition (prolapse)</LI>
<LI>urinary incontinence</LI>
<LI>psychological functioning</LI>
<LI>sexual functioning</LI>
<LI>menopausal symptoms</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-07-24 14:48:26 +1200" MODIFIED_BY="Helen E Nagels">
<P>
<BR/>
</P>
<ELECTRONIC_SEARCHES MODIFIED="2014-07-24 14:48:26 +1200" MODIFIED_BY="Helen E Nagels">
<P>For the 2014 update of the review we searched for all published and unpublished RCTs, without language restrictions and in consultation with the Menstrual Disorders and Subfertility Group (MDSG) Trials Search Co-ordinator, in the Cochrane MDSG Specialised Register (August 2007 to January 2014), CENTRAL (<I>The Cochrane Library </I>2013, Issue 12), MEDLINE (October 2007 to January 2014), EMBASE (October to January 2014) and PsycINFO (October 2007 to January 2014). The search strategies for each database are described in the appendices (Appendices 1, 2, 3, 4 and 5).</P>
<P>For the previous version of this review we searched the Cochrane MDSG Specialised Register (December 2005 to October 2007), CENTRAL (<I>The Cochrane Library </I>2007, Issue 4), EMBASE (January 1985 to October 2007), MEDLINE (January 1966 to October 2007), LILACS (January 1982 to October 2007), Biological Abstracts (January 1968 to October 2007), NHS Economic Evaluation Database (from inception to October 2007), Health Technology Assessment Database (from inception to October 2007) and the Meta RCTs (from inception to October 2007). (<LINK REF="REF-Orozco-2008a" TYPE="REFERENCE">Orozco 2008a</LINK>)</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2014-07-05 17:52:31 +1200" MODIFIED_BY="[Empty name]">
<P>For the 2014 version of this review we requested, but have not yet received, information about a pilot RCT on elective bilateral salpingo-oophorectomy versus ovarian conservation in women aged 40 to 55 years, registered at the ClinicalTrials website in 2009, for which the results have not yet been published (<LINK REF="STD-Jacoby-2009" TYPE="STUDY">Jacoby 2009</LINK>).</P>
<P>For the previous version of this review the reference lists of articles retrieved by the search were handsearched and personal contact was made with experts in the field to obtain any additional relevant data. For the original version of the review, authors of main studies were contacted to ascertain if they were aware of any additional published or unpublished studies. We asked two study authors (V Jacoby MD, from the Department of Obstetrics, Gynecology and Reproductive Sciences of the University of California, USA; A Aziz MD, from the Department of Obstetrics and Gynecology, Sahlgrenska Academy at Göteborg University, Sweden) to provide additional data. Dr Jacoby responded.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-07-05 18:02:15 +1200" MODIFIED_BY="[Empty name]">
<P>Data collection and analysis were conducted in accordance with the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).<BR/>
</P>
<STUDY_SELECTION MODIFIED="2014-07-05 17:54:27 +1200" MODIFIED_BY="[Empty name]">
<P>Two review authors (LJOS, MT) independently assessed all the abstracts of the studies retrieved from searches to identify those potentially qualifying for inclusion. Full text versions of those studies considered to potentially qualify for inclusion were obtained. Two review authors (MT, MV) determined whether each individual study met the inclusion criteria, or not, using an eligibility form based on our inclusion criteria.<BR/>
</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-05-27 13:41:14 +1200" MODIFIED_BY="[Empty name]">
<P> We planned that data would be extracted by two of LJOS, AS and MT using a data extraction form based on the primary and secondary outcomes. We intended to extract information on the study design, participants, interventions, outcomes, study risk of bias and the main results of the study.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-06-25 07:56:07 +1200" MODIFIED_BY="[Empty name]">
<P>We planned to use the Cochrane risk of bias tool to assess the risk of bias of the included studies and we intended to resolve any differences of opinion by consensus.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2014-07-05 17:55:35 +1200" MODIFIED_BY="[Empty name]">
<P>We planned to use the Peto odds ratio for dichotomous data and mean difference for continuous data, with 95% confidence intervals. We planned to treat ordinal data (for example quality of life scores) as continuous data.<BR/>
</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2014-06-25 07:56:35 +1200" MODIFIED_BY="[Empty name]">
<P>We planned for the primary analysis to be per woman randomised.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2014-07-05 17:57:54 +1200" MODIFIED_BY="[Empty name]">
<P>We planned to analyse the data on an intention-to-treat basis as far as possible. We intended to contact trial authors to request data for unreported data on outcomes or clarification of methodological uncertainties. We planned to undertake imputation of individual data for the primary outcomes only if these data could not be obtained. If studies reported sufficient detail to calculate mean differences but no information on associated standard deviations (SD), we planned to assume the outcome to have a SD equal to the highest SD from other studies within the same analysis. For other outcomes, we intended to analyse only the available data. We planned to do sensitivity analysis on any imputation undertaken.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-07-05 17:58:26 +1200" MODIFIED_BY="[Empty name]">
<P>The authors planned to consider whether the clinical and methodological characteristics of the included studies were sufficiently similar for meta-analysis to provide a meaningful summary. We planned to assess statistical heterogeneity with the Chi<SUP>2</SUP> test and the I<SUP>2</SUP> statistic (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2014-07-05 17:58:49 +1200" MODIFIED_BY="[Empty name]">
<P>In view of the difficulty in detecting and correcting for publication bias and other reporting biases, the authors aimed to minimise their potential impact by ensuring a comprehensive search for eligible studies and by being alert for duplication of data. If there had been 10 or more studies in an analysis, we planned to construct a funnel plot to explore the possibility of small study effects (a tendency for estimates of the intervention effect to be more beneficial in smaller studies). We planned to assess for within study reporting bias by seeking published protocols and comparing the outcomes between the protocol and the final published study.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-07-05 17:59:29 +1200" MODIFIED_BY="[Empty name]">
<P>If several comparable RCTs could be identified, we planned to carry out a meta-analysis to summarise their results using a fixed-effect model.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2014-07-05 17:59:44 +1200" MODIFIED_BY="[Empty name]">
<P>In the case of evidence of substantial heterogeneity (I<SUP>2</SUP> &gt; 50%), we planned to check the effect of using a random-effects model and perform subgroup analyses to examine the effects of age, presence of endometriosis, non-gynaecological comorbidity at the time of the surgery and HT use.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2014-07-05 18:02:15 +1200" MODIFIED_BY="[Empty name]">
<P>We planned to conduct sensitivity analysis to determine whether the conclusions would be robust to arbitrary decisions made regarding the eligibility and analysis of studies, as follows:</P>
<UL>
<LI>restriction of analysis to studies with low risk of bias;</LI>
<LI>use of risk ratios rather than odds ratios.</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="3">Summary of findings</HEADING>
<P>We planned to present a summary of findings table using Guideline Development Tool software. This table would evaluate the overall quality of the body of evidence for the primary review outcomes (mortality and and future gynaecological surgical interventions) using the GRADE criteria (study limitations (that is risk of bias), consistency of effect, imprecision, indirectness and publication bias). Judgements about evidence quality (high, moderate or low) were to be justified, documented, and incorporated into reporting of results for each outcome.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-07-05 18:09:18 +1200" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2014-07-05 18:08:23 +1200" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<SEARCH_RESULTS MODIFIED="2014-07-05 18:03:24 +1200" MODIFIED_BY="[Empty name]">
<P>We identified 119 abstracts in the original review and 251 records in this update, which were screened for inclusion. Three abstracts, reporting on two studies, had been identified as potentially relevant for the previous version of this review (<LINK REF="STD-Aziz-2005" TYPE="STUDY">Aziz 2005</LINK>;<U> </U>Aziz 2005b; <LINK REF="STD-Teplin-2007" TYPE="STUDY">Teplin 2007</LINK>). For the current update of the review two more records were identified (<LINK REF="STD-Ellstrom-2010" TYPE="STUDY">Ellstrom 2010</LINK>; <LINK REF="STD-Jacoby-2009" TYPE="STUDY">Jacoby 2009</LINK>). See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-07-05 18:04:37 +1200" MODIFIED_BY="[Empty name]">
<P>Only one (pilot) RCT was identified that compared hysterectomy without oophorectomy with hysterectomy plus oophorectomy. The trial was identified on a trial registration website and has been completed but the results have not been published. The author did not make the data available for this review (<LINK REF="STD-Jacoby-2009" TYPE="STUDY">Jacoby 2009</LINK>).<BR/>
</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-07-05 18:08:23 +1200" MODIFIED_BY="[Empty name]">
<P>Four studies (<LINK REF="STD-Aziz-2005" TYPE="STUDY">Aziz 2005</LINK>; <LINK REF="STD-Ellstrom-2010" TYPE="STUDY">Ellstrom 2010</LINK>; <LINK REF="STD-Orozco-2008" TYPE="STUDY">Orozco 2008</LINK>; <LINK REF="STD-Teplin-2007" TYPE="STUDY">Teplin 2007</LINK>) were identified as potentially relevant but were excluded for the following reasons.<B>
<BR/>
</B>
</P>
<UL>
<LI>Study design: the studies by Aziz et al (<LINK REF="STD-Aziz-2005" TYPE="STUDY">Aziz 2005</LINK>) and Teplin et al (<LINK REF="STD-Teplin-2007" TYPE="STUDY">Teplin 2007</LINK>) were excluded based on the design of the studies, as both studies did not have a RCT design.</LI>
</UL>
<UL>
<LI>Interventions: the study by Ellstrom et al (<LINK REF="STD-Ellstrom-2010" TYPE="STUDY">Ellstrom 2010</LINK>) was excluded because the intervention that was investigated in this study was not hysterectomy without or with oophorectomy; the study by Teplin et al (<LINK REF="STD-Teplin-2007" TYPE="STUDY">Teplin 2007</LINK>) did not investigate the interventions hysterectomy with or without oophorectomy but compared the interventions total hysterectomy and supravaginal hysterectomy. This was another reason to exclude this study.</LI>
</UL>
<UL>
<LI>Data unavailable:<B> </B>the study <LINK REF="STD-Orozco-2008" TYPE="STUDY">Orozco 2008</LINK> was planned but has not been conducted.</LI>
</UL>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-07-05 18:08:52 +1200" MODIFIED_BY="[Empty name]">
<P>Because insufficient details were available about the included study (<LINK REF="STD-Jacoby-2009" TYPE="STUDY">Jacoby 2009</LINK>), we were unable to assess the risk of bias.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-07-05 18:09:18 +1200" MODIFIED_BY="[Empty name]">
<P>Because no data were available for the included study (<LINK REF="STD-Jacoby-2009" TYPE="STUDY">Jacoby 2009</LINK>) no effects of the interventions could be reported.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-07-05 18:18:05 +1200" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<SUMMARY_OF_RESULTS MODIFIED="2014-07-05 18:11:10 +1200" MODIFIED_BY="[Empty name]">
<P>No RCTs were found that compare the benefits and harms of conservation of the ovaries with prophylactic oophorectomy at the time of hysterectomy for benign gynaecological disease in premenopausal women, except for a pilot RCT for which the results were not available for this review. Therefore, this systematic review does not provide evidence from RCTs to support clinicians and women in the decision whether to remove or conserve the ovaries at the time of hysterectomy.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-02-21 05:40:52 +1300" MODIFIED_BY="[Empty name]">
<P>The objective of this review was to locate and synthesise the evidence regarding a controversial clinical question in women&#8217;s health, which remains unanswered.<BR/>
</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-07-05 18:11:46 +1200" MODIFIED_BY="[Empty name]">
<P>Because of the lack of available data, this review does not provide evidence from RCTs on the benefits and harms of oophorectomy or conservation of the ovaries at the time of hysterectomy.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2014-07-05 18:12:22 +1200" MODIFIED_BY="[Empty name]">
<P>Only one pilot RCT was found comparing hysterectomy without oophorectomy and hysterectomy plus oophorectomy, for which the results were not available for this review. It is unlikely that we missed information from other unpublished RCTs due to publication bias because of the extensive search strategy and the difficulty of conducting a RCT on this subject.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2014-07-05 18:18:05 +1200" MODIFIED_BY="[Empty name]">
<P>This review does not provide evidence to recommend or discourage prophylactic bilateral oophorectomy in premenopausal women because no RCTs that examined hysterectomy without or with oophorectomy could be included.</P>
<P>In the previous version of the review one observational study was included that investigated psychological and sexual well-being and the climacteric symptoms of women after hysterectomy with and without oophorectomy (<LINK REF="STD-Aziz-2005" TYPE="STUDY">Aziz 2005</LINK>). This study demonstrated that prophylactic oophorectomy at the time of hysterectomy did not negatively affect sexual and psychological well-being in women using HT, but the quality of the evidence was considered low because of methodological limitations of the study. Because the current review only included studies with a RCT design, this study was excluded from the review.</P>
<P>The lack of RCTs on hysterectomy with or without oophorectomy may be explained by the unfeasibility of conducting a RCT on this topic, due to the difficulty of recruiting women willing to participate in a RCT in which they cannot choose whether or not their ovaries will be removed. Jacoby et al (<LINK REF="STD-Jacoby-2009" TYPE="STUDY">Jacoby 2009</LINK>) conducted a pilot study to assess the feasibility of a RCT on hysterectomy with or without oophorectomy; unfortunately the results of this study have not been published yet. Orozco et al have registered a protocol for a RCT on prophylactic oophorectomy at the time of hysterectomy in menopausal women (<LINK REF="STD-Orozco-2008" TYPE="STUDY">Orozco 2008</LINK>). This study has not been conducted yet and is still awaiting approval from the ethical committee in El Salvador.</P>
<P>Recently the results of a prospective cohort study of 30,117 participants of the Nurses&#8217; Health Study have been published (<LINK REF="REF-Parker-2013" TYPE="REFERENCE">Parker 2013</LINK>). This study demonstrated, after a follow-up period of 28 years, a lower risk of mortality from ovarian cancer in women who had had a bilateral oophorectomy, and a lower risk of breast cancer in women younger than 47.5 years who had had an oophorectomy. However, all cause mortality was higher in the women with oophorectomy and also in those who were younger than 50 years and never used HT. Furthermore, in this study hysterectomy with oophorectomy was at no age associated with increased survival (<LINK REF="REF-Parker-2013" TYPE="REFERENCE">Parker 2013</LINK>). Because this was an observational study without randomised allocation to either oophorectomy or ovarian conservation the results may have been subject to selection bias, but as women in both groups were similar in baseline characteristics this may have been of limited importance. The findings may have been influenced by confounding due to differences in use of medication (statins for example) or diet. Because the participants of the Nurses&#8217; Health Study are mainly white women, the results may not be generalizable to other populations of women.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-07-05 18:22:58 +1200" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2014-07-05 18:20:30 +1200" MODIFIED_BY="[Empty name]">
<P>In clinical practice the controversial decision of whether to perform prophylactic bilateral oophorectomy at the time of hysterectomy in premenopausal women remains at the discretion of the clinician rather than based on evidence obtained from randomised controlled studies. Evidence on the benefits and harms of a bilateral oophorectomy with hysterectomy derives solely from observational studies. These have not demonstrated higher all cause mortality rates in women who had a hysterectomy with ovarian conservation. The evidence provided by observational studies does not support high numbers of prophylactic oophorectomy in premenopausal women without BRCA mutations. Until more data become available, prophylactic oophorectomy should be approached with great caution. The clinician must consider the individual implications for each woman with regard to her baseline risk for developing breast and ovarian cancer, coronary heart disease, and osteoporotic hip fracture.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-07-05 18:22:58 +1200" MODIFIED_BY="[Empty name]">
<P>There remains a need for randomised controlled trials designed to resolve this question. We do not think it likely that more randomised controlled trials will be carried out on this subject, although we keenly await publication of the results of <LINK REF="STD-Jacoby-2009" TYPE="STUDY">Jacoby 2009</LINK> and we do hope that the Orozco study (<LINK REF="STD-Orozco-2008" TYPE="STUDY">Orozco 2008</LINK>) will be carried out in the near future. However, in default of results from randomised controlled trials, we think that a systematic review of high quality observational studies may be useful to assist clinicians and patients in the choice of conservation or removal of the ovaries at the time of hysterectomy.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-07-24 14:51:40 +1200" MODIFIED_BY="Helen E Nagels">
<P>We would like to thank Marian Showell, Trials Search Coordinator, and Helen Nagels, Managing Editor of the Menstrual Disorders and Subfertility Group for their assistance. </P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2014-07-05 18:23:22 +1200" MODIFIED_BY="[Empty name]">
<P>None known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2014-05-08 15:07:42 +1200" MODIFIED_BY="[Empty name]">
<P>Leonardo Orozco, Mario Tristan, Maria Vreugdenhil and Arturo Salazar planned, co-drafted, and finalised the review update.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2014-07-05 18:23:51 +1200" MODIFIED_BY="[Empty name]">
<P>We modified the original search strategy that was published in the protocol for this review, see the appendices. We changed the inclusion criteria for type of studies; this updated version only includes RCTs and not controlled or observational trials.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-07-28 09:59:28 +1200" MODIFIED_BY="Helen E Nagels">
<STUDIES MODIFIED="2014-07-28 09:54:01 +1200" MODIFIED_BY="Helen E Nagels">
<INCLUDED_STUDIES MODIFIED="2014-07-28 09:54:01 +1200" MODIFIED_BY="Helen E Nagels">
<STUDY DATA_SOURCE="PUB" ID="STD-Jacoby-2009" MODIFIED="2014-07-28 09:54:01 +1200" MODIFIED_BY="Helen E Nagels" NAME="Jacoby 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-07-28 09:54:01 +1200" MODIFIED_BY="Helen E Nagels" PRIMARY="NO" TYPE="OTHER">
<AU>Jacoby VL</AU>
<TI>Bilateral oophorectomy versus ovarian conservation, a pilot randomized controlled trial</TI>
<SO>NCT01007305, ClinicalTrials.gov</SO>
<YR>available at http://www.clinicaltrials.gov</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-07-05 18:31:37 +1200" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Aziz-2005" MODIFIED="2014-07-05 18:31:12 +1200" MODIFIED_BY="[Empty name]" NAME="Aziz 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-07-05 18:31:12 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aziz A, Bergquist C, Nordholm L, Moller A, Silfverstolpe G</AU>
<TI>Prophylactic oophorectomy at elective hysterectomy. Effects on psychological well-being at 1-year follow-up and its correlations to sexuality</TI>
<SO>Maturitas</SO>
<YR>2005</YR>
<VL>51</VL>
<PG>349&#8211;57</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-20 14:12:43 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aziz A, Brännström M, Bergquist C, Silfverstolpe G</AU>
<TI>Androgen decline after oophorectomy does not influence sexuality or psychological well-being</TI>
<SO>Fertility and Sterility</SO>
<YR>2005</YR>
<VL>83</VL>
<NO>4</NO>
<PG>1021-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-04-12 04:15:00 +1200" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ellstrom-2010" MODIFIED="2014-07-05 18:31:37 +1200" MODIFIED_BY="[Empty name]" NAME="Ellstrom 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-07-05 18:31:37 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ellstrom Engh MA, Jerhamre K, Junskog K</AU>
<TI>A randomized trial comparing changes in sexual health and psychological well-being after subtotal and total hysterectomies</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>2010</YR>
<VL>89</VL>
<NO>1</NO>
<PG>65-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Orozco-2008" MODIFIED="2014-05-20 14:13:26 +1200" MODIFIED_BY="[Empty name]" NAME="Orozco 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-05-20 14:13:26 +1200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Orzoco LJ, Aguilar R, Tristan M, Montiel G, Córdova E</AU>
<TI>Central American research on prophylactic ovariectomy amongst menopausal women</TI>
<SO>Australian New Zealand Clinical Trials Registry</SO>
<YR>2008</YR>
<VL>Trial ID ACTRN1208000589381</VL>
<NO>available at http://www.anzctr.org.au</NO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Teplin-2007" MODIFIED="2008-04-01 14:29:43 +1300" MODIFIED_BY="jane clarke" NAME="Teplin 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-04-01 14:29:43 +1300" MODIFIED_BY="jane clarke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Teplin V, Vittinghoff E, Lin F, Learman LA, Richter H, Kuppermann M</AU>
<TI>Oophorectomy in premenopausal women. Health-related quality of life and sexual functioning</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2007</YR>
<VL>109</VL>
<PG>347&#8211;54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES MODIFIED="2014-05-08 13:16:15 +1200" MODIFIED_BY="[Empty name]"/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-07-28 09:59:28 +1200" MODIFIED_BY="Helen E Nagels">
<ADDITIONAL_REFERENCES MODIFIED="2014-07-28 09:59:28 +1200" MODIFIED_BY="Helen E Nagels">
<REFERENCE ID="REF-ACOG-2008" MODIFIED="2014-07-05 18:32:28 +1200" MODIFIED_BY="[Empty name]" NAME="ACOG 2008" TYPE="JOURNAL_ARTICLE">
<AU>American College of Obstetricians and Gynecologists</AU>
<TI>Clinical Management Guidelines for Obstetrician-Gynecologists</TI>
<SO>ACOG Practice Bulletin 89 Washington, DC</SO>
<YR>2008</YR>
<PG>231&#8211;41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Casiano-2013" MODIFIED="2014-04-11 09:12:18 +1200" MODIFIED_BY="[Empty name]" NAME="Casiano 2013" TYPE="JOURNAL_ARTICLE">
<AU>Casiano ER, Trabuco EC, Bharucha AE, Weaver AL, Schleck CD, Melton LJ, et al</AU>
<TI>Risk of oophorectomy after hysterectomy</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2013</YR>
<VL>121</VL>
<NO>5</NO>
<PG>1069&#8211;74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CDC-2006" NAME="CDC 2006" TYPE="COMPUTER_PROGRAM">
<TI>Women's Reproductive Health: Hysterectomy</TI>
<YR>2006</YR>
<PB>Dept Health and Human Services CDC</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guptaa-2006" NAME="Guptaa 2006" TYPE="JOURNAL_ARTICLE">
<AU>Guptaa S, Manyonda I</AU>
<TI>Hysterectomy for benign gynaecological disease</TI>
<SO>Current Obstetrics &amp; Gynaecology</SO>
<YR>2006</YR>
<VL>16</VL>
<NO>3</NO>
<PG>147-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2014-07-24 14:31:27 +1200" MODIFIED_BY="Helen E Nagels" NAME="Higgins 2011" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</TI>
<SO>The Cochrane Collaboration</SO>
<YR>2011. Available from www.cochrane-handbook.org</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-2005" MODIFIED="2008-04-01 14:34:43 +1300" MODIFIED_BY="jane clarke" NAME="Johnson 2005" TYPE="JOURNAL_ARTICLE">
<AU>Johnson N, Barlow D, Lethaby A, Tavender E, Curr L, Garry R</AU>
<TI>Methods of hysterectomy: systematic review and meta-analysis of randomised controlled trials</TI>
<SO>BMJ</SO>
<YR>2005</YR>
<VL>330</VL>
<NO>7506</NO>
<PG>1478</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Judd-1974" NAME="Judd 1974" TYPE="JOURNAL_ARTICLE">
<AU>Judd HL, Judd GE, Lucas WE, Yen SS</AU>
<TI>Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood</TI>
<SO>Journal of Clinical Endocrinology and Metabolism</SO>
<YR>1974</YR>
<VL>39</VL>
<PG>1020-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Main-2013" MODIFIED="2014-07-28 09:59:28 +1200" MODIFIED_BY="Helen E Nagels" NAME="Main 2013" TYPE="COCHRANE_REVIEW">
<AU>Main C, Knight B, Moxham T, Gabriel Sanchez R, Sanchez Gomez LM, Roqué i Figuls M, Bonfill Cosp X</AU>
<TI>Hormone therapy for preventing cardiovascular disease in post-menopausal women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2014-07-28 09:59:28 +1200" MODIFIED_BY="Helen E Nagels">
<IDENTIFIER MODIFIED="2014-07-28 09:59:28 +1200" MODIFIED_BY="Helen E Nagels" TYPE="DOI" VALUE="10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Marjoribanks-2012" MODIFIED="2014-07-28 09:58:24 +1200" MODIFIED_BY="Helen E Nagels" NAME="Marjoribanks 2012" TYPE="COCHRANE_REVIEW">
<AU>Marjoribanks J, Farquhar C, Roberts H, Lethaby A</AU>
<TI>Long term hormone therapy for perimenopausal and postmenopausal women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2014-07-28 09:58:24 +1200" MODIFIED_BY="Helen E Nagels">
<IDENTIFIER MODIFIED="2014-07-28 09:58:24 +1200" MODIFIED_BY="Helen E Nagels" TYPE="DOI" VALUE="10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mavaddat-2013" MODIFIED="2014-07-24 14:32:13 +1200" MODIFIED_BY="Helen E Nagels" NAME="Mavaddat 2013" TYPE="JOURNAL_ARTICLE">
<AU>Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, et al</AU>
<TI>Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>2013</YR>
<VL>105</VL>
<NO>11</NO>
<PG>812&#8211;22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olive-2005" MODIFIED="2008-04-01 14:38:52 +1300" MODIFIED_BY="jane clarke" NAME="Olive 2005" TYPE="OTHER">
<AU>Olive DL</AU>
<TI>Dogma, skepsis, and the analytic method: the role of prophylactic oophorectomy at the time of hysterectomy</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2005</YR>
<VL>106</VL>
<NO>2</NO>
<PG>214-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Orozco-2008a" MODIFIED="2014-07-24 14:43:03 +1200" MODIFIED_BY="Helen E Nagels" NAME="Orozco 2008a" TYPE="COCHRANE_REVIEW">
<AU>Orozco L, Clark J, Salazar A, Tristan M</AU>
<TI>Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2014-04-30 13:34:24 +1200" MODIFIED_BY="Mario Tristan">
<IDENTIFIER MODIFIED="2014-04-30 13:34:24 +1200" MODIFIED_BY="Mario Tristan" TYPE="DOI" VALUE="10.1002/14651858.CD005638.pub2."/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Parker-2009" MODIFIED="2014-02-21 09:56:44 +1300" MODIFIED_BY="[Empty name]" NAME="Parker 2009" TYPE="JOURNAL_ARTICLE">
<AU>Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, et al</AU>
<TI>conservation at the time of hysterectomy and long-term health outcomes in the nurses&#8217; health study</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2009 May</YR>
<VL>113</VL>
<NO>5</NO>
<PG>1027&#8211;37</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Parker-2013" MODIFIED="2014-02-21 09:54:32 +1300" MODIFIED_BY="[Empty name]" NAME="Parker 2013" TYPE="JOURNAL_ARTICLE">
<AU>Parker WH, Feskanich D, Broder MS, Chang E, Shoupe D, Farquhar CM, et al</AU>
<TI>Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses&#8217; health study</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2013 May</YR>
<VL>121</VL>
<NO>4</NO>
<PG>709&#8211;16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Perera-2013" MODIFIED="2014-07-05 18:50:10 +1200" MODIFIED_BY="[Empty name]" NAME="Perera 2013" TYPE="JOURNAL_ARTICLE">
<AU>Perera HK, Ananth C V, Richards CA, Neugut AI, Lewin SN, Lu Y-S, et al</AU>
<TI>Variation in ovarian conservation in women undergoing hysterectomy for benign indications</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2013 May</YR>
<VL>121</VL>
<NO>4</NO>
<PG>717&#8211;26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rebbeck-2002" MODIFIED="2014-07-05 18:50:29 +1200" MODIFIED_BY="[Empty name]" NAME="Rebbeck 2002" TYPE="JOURNAL_ARTICLE">
<AU>Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, et al.</AU>
<TI>Prophylactic oophorectomy in carriers of BRAC1 or BRAC2 mutations</TI>
<SO>The New England Journal of Medicine</SO>
<YR>2002</YR>
<VL>346</VL>
<NO>21</NO>
<PG>1616&#8211;22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rivera-2009" MODIFIED="2014-02-21 10:01:03 +1300" MODIFIED_BY="[Empty name]" NAME="Rivera 2009" TYPE="JOURNAL_ARTICLE">
<AU>Rivera CM, Grossardt BR, Rhodes DJ, Brown RD, Roger VL, Melton LJ, et al</AU>
<TI>Increased cardiovascular mortality after early bilateral oophorectomy</TI>
<SO>Menopause</SO>
<YR>2009</YR>
<VL>16</VL>
<NO>1</NO>
<PG>15&#8211;23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rocca-2006" MODIFIED="2014-07-05 18:51:01 +1200" MODIFIED_BY="[Empty name]" NAME="Rocca 2006" TYPE="JOURNAL_ARTICLE">
<AU>Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ</AU>
<TI>Patterns after oophorectomy in premenopausal women: a population-based cohort study</TI>
<SO>Lancet Oncology</SO>
<YR>2006 Oct</YR>
<VL>7</VL>
<NO>10</NO>
<PG>821&#8211;8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rocca-2007" MODIFIED="2014-02-21 10:05:59 +1300" MODIFIED_BY="[Empty name]" NAME="Rocca 2007" TYPE="JOURNAL_ARTICLE">
<AU>Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, et al</AU>
<TI>Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause</TI>
<SO>Neurology</SO>
<YR>2007 Sep</YR>
<VL>69</VL>
<NO>11</NO>
<PG>1074&#8211;83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-SEER-2013" MODIFIED="2014-07-05 18:51:31 +1200" MODIFIED_BY="[Empty name]" NAME="SEER 2013" TYPE="OTHER">
<AU>Surveillance, Epidemiology and End Results Program</AU>
<TI>National Cancer Institute</TI>
<SO>Available at: http://seer.cancer.gov/statfacts/html/ovary.html</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Svejme-2012" MODIFIED="2014-02-21 10:10:36 +1300" MODIFIED_BY="[Empty name]" NAME="Svejme 2012" TYPE="JOURNAL_ARTICLE">
<AU>Svejme O, Ahlborg HG, Nilsson J-Å, Karlsson MK</AU>
<TI>Early menopause and risk of osteoporosis, fracture and mortality: a 34-year prospective observational study in 390 women</TI>
<SO>BJOG</SO>
<YR>2012 Jun</YR>
<VL>119</VL>
<NO>7</NO>
<PG>810&#8211;6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zalel-1997" MODIFIED="2008-04-01 14:43:49 +1300" MODIFIED_BY="jane clarke" NAME="Zalel 1997" TYPE="JOURNAL_ARTICLE">
<AU>Zalel Y, Lurie S, Beyth Y, Goldberger S, Tepper R</AU>
<TI>Is it necessary to perform a prophylactic oophorectomy during hysterectomy?</TI>
<SO>European Journal of Obstetrics, Gynecology, and Reproductive Biology</SO>
<YR>1997</YR>
<VL>73</VL>
<NO>1</NO>
<PG>67-70</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-07-05 18:30:49 +1200" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-07-05 18:29:29 +1200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-07-05 18:29:29 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jacoby-2009">
<CHAR_METHODS MODIFIED="2014-07-05 18:24:38 +1200" MODIFIED_BY="[Empty name]">
<P>Allocation: Randomized</P>
<P>Intervention model: Parallel assignment</P>
<P>Masking: Double blind (subject, investigator, outcomes assessor)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-07-05 18:26:05 +1200" MODIFIED_BY="[Empty name]">
<P>Women 40 years to 55 years</P>
<P>Inclusion criteria:</P>
<OL>
<LI>Plans to undergo hysterectomy for any non-cancerous gynaecologic condition, including symptomatic fibroids, abnormal bleeding, pelvic pain, or pelvic organ prolapse. Hysterectomy may be done abdominally, vaginally or laparoscopically</LI>
<LI>Premenopausal defined as having at least one menses in the 3 months prior to surgery</LI>
<LI>Age &#8805; 40 years</LI>
<LI>Speaks English or Spanish</LI>
</OL>
<P>Exclusion criteria:</P>
<OL>
<LI>Personal or family history of breast and/or ovarian cancer (at least one first degree relative with a diagnosis of breast or ovarian cancer) or a known BRCA mutation</LI>
<LI>Known or suspected adnexal mass by physical examination or radiologic imaging study</LI>
<LI>Gynaecologist recommends BSO for treatment of pelvic pain and/or endometriosis</LI>
<LI>Known history of coronary heart disease defined as any of the following: prior myocardial infarction, history of angioplasty, history of angina, admission to the hospital for evaluation of chest pain, or use of nitroglycerin to treat angina</LI>
<LI>History of stroke</LI>
<LI>History of osteoporosis</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-07-05 18:26:45 +1200" MODIFIED_BY="[Empty name]">
<P>Experimental: Bilateral salpingo-oophorectomy</P>
<P>Removal of both ovaries and fallopian tubes at the time of hysterectomy for benign conditions</P>
<P>Active comparator: Ovarian conservation</P>
<P>No ovaries or fallopian tubes removed at the time of hysterectomy for benign conditions</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-07-05 18:28:33 +1200" MODIFIED_BY="[Empty name]">
<UL>
<LI>Recruitment rate [Time Frame: start of study] [Designated as safety issue: No]</LI>
<LI>Flow-mediated diameter of the brachial artery [Time Frame: Baseline and 6 months follow-up] [Designated as safety issue: No]</LI>
<LI>Serum bone turnover markers [Time Frame: Baseline and 6 months follow-up] [Designated as safety issue: No]</LI>
<LI>Sexual functioning and quality of life questionnaires [Time Frame: Baseline and 6 months follow-up] [Designated as safety issue: No]</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-07-05 18:29:29 +1200" MODIFIED_BY="[Empty name]">
<P>Pilot study to assess the feasibility of conducting a randomised, blinded, controlled trial of bilateral salpingo-oophorectomy (BSO, removal of the ovaries and fallopian tubes) versus ovarian conservation among premenopausal women age 40 years and greater who planned to undergo hysterectomy for a benign gynecologic condition. <BR/>Subjects will be randomised to BSO or ovarian conservation concomitant with hysterectomy and remain blinded to group assignment.</P>
<P>May 2009 to April 2011</P>
<P>All information is from the clinicaltrials.gov website</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2014-07-05 18:30:49 +1200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2014-04-12 12:55:46 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aziz-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-04-12 12:55:46 +1200" MODIFIED_BY="[Empty name]">
<P>This study did not have a RCT design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-07-05 18:30:17 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ellstrom-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-07-05 18:30:17 +1200" MODIFIED_BY="[Empty name]">
<P>This RCT compared sexual health and psychological well-being in women after subtotal and total hysterectomy. It did not compare the interventions hysterectomy without oophorectomy and hysterectomy with oophorectomy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-07-05 18:30:20 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Orozco-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-07-05 18:30:20 +1200" MODIFIED_BY="[Empty name]">
<P>Trial planned but not carried out</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-07-05 18:30:49 +1200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Teplin-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-07-05 18:30:49 +1200" MODIFIED_BY="[Empty name]">
<P>The design of this study was not a RCT. The study was a secondary analysis of data from a RCT comparing total hysterectomy with supravaginal hysterectomy. Participants had not been randomised according to the intervention hysterectomy without or with oophorectomy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2014-05-08 13:16:15 +1200" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-05-14 12:24:32 +1200" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-05-14 12:23:40 +1200" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-05-14 12:24:32 +1200" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-02-16 13:54:36 +1300" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2014-05-14 12:24:32 +1200" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2014-05-14 12:24:32 +1200" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-05-14 12:24:32 +1200" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2014-05-14 12:24:32 +1200" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2014-05-14 12:24:32 +1200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2008-07-21 14:06:38 +1200" MODIFIED_BY="jane clarke"/>
<ADDITIONAL_TABLES MODIFIED="2014-02-16 13:57:00 +1300" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-02-16 14:15:46 +1300" MODIFIED_BY="[Empty name]"/>
<FIGURES MODIFIED="2014-07-05 18:52:13 +1200" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-07-05 18:52:13 +1200" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>PRISMA.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArIAAAH7CAYAAAAwxny5AABR8ElEQVR42u2dcYRVz///3yRJkkiy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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-05-14 12:49:36 +1200" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2014-02-26 19:56:18 +1300" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-04-01 13:39:20 +1300" MODIFIED_BY="jane clarke">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-02-26 19:56:18 +1300" MODIFIED_BY="[Empty name]">
<P>1 exp perimenopause/ or exp premenopause/ (13853)<BR/>2 pre$menopaus$.tw. (13361)<BR/>3 peri$menopaus$.tw. (3165)<BR/>4 or/1-3 (22447)<BR/>5 exp Hysterectomy/ (33208)<BR/>6 hysterectom$.tw. (24970)<BR/>7 exp OVARIECTOMY/ (21097)<BR/>8 Ovariectom$.tw. (19862)<BR/>9 oophorectom$.tw. (6324)<BR/>10 or/5-6 (39505)<BR/>11 or/7-9 (31657)<BR/>12 10 and 11 (4561)<BR/>13 4 and 12 (321)<BR/>14 Clinical Trial/ (810344)<BR/>15 Randomized Controlled Trial/ (282199)<BR/>16 exp randomization/ (52560)<BR/>17 Single Blind Procedure/ (13388)<BR/>18 Double Blind Procedure/ (99421)<BR/>19 Crossover Procedure/ (29371)<BR/>20 Placebo/ (168808)<BR/>21 Randomi?ed controlled trial$.tw. (56645)<BR/>22 Rct.tw. (5994)<BR/>23 random allocation.tw. (992)<BR/>24 randomly allocated.tw. (14696)<BR/>25 allocated randomly.tw. (1673)<BR/>26 (allocated adj2 random).tw. (677)<BR/>27 Single blind$.tw. (10423)<BR/>28 Double blind$.tw. (113531)<BR/>29 ((treble or triple) adj blind$).tw. (225)<BR/>30 placebo$.tw. (151100)<BR/>31 prospective study/ (156334)<BR/>32 or/14-31 (1089273)<BR/>33 case study/ (10349)<BR/>34 case report.tw. (191711)<BR/>35 abstract report/ or letter/ (755895)<BR/>36 or/33-35 (954413)<BR/>37 32 not 36 (1057585)<BR/>38 13 and 37 (63)<BR/>
<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2014-02-26 19:56:28 +1300" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2008-04-01 13:43:54 +1300" MODIFIED_BY="jane clarke">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-02-26 19:56:28 +1300" MODIFIED_BY="[Empty name]">
<P>1 exp perimenopause/ or exp premenopause/ (5459)<BR/>2 pre$menopaus$.tw. (11836)<BR/>3 peri$menopaus$.tw. (2578)<BR/>4 or/1-3 (15407)<BR/>5 exp Hysterectomy/ (21523)<BR/>6 hysterectom$.tw. (21331)<BR/>7 exp Ovariectomy/ (17944)<BR/>8 Ovariectom$.tw. (19802)<BR/>9 oophorectom$.tw. (5728)<BR/>10 or/5-6 (30831)<BR/>11 or/7-9 (30607)<BR/>12 10 and 11 (4144)<BR/>13 4 and 12 (248)<BR/>14 randomized controlled trial.pt. (302726)<BR/>15 controlled clinical trial.pt. (82927)<BR/>16 randomized.ab. (208354)<BR/>17 placebo.tw. (126990)<BR/>18 clinical trials as topic.sh. (151928)<BR/>19 randomly.ab. (151883)<BR/>20 trial.ti. (89881)<BR/>21 (crossover or cross-over or cross over).tw. (47058)<BR/>22 or/14-21 (715052)<BR/>23 exp animals/ not humans.sh. (3583071)<BR/>24 22 not 23 (659598)<BR/>25 13 and 24 (34)<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2014-02-26 19:56:40 +1300" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2008-04-01 13:47:23 +1300" MODIFIED_BY="jane clarke">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-02-26 19:56:40 +1300" MODIFIED_BY="[Empty name]">
<P>1 exp perimenopause/ or exp premenopause/ (591)<BR/>2 pre$menopaus$.tw. (1607)<BR/>3 peri$menopaus$.tw. (297)<BR/>4 or/1-3 (1941)<BR/>5 exp Hysterectomy/ (1279)<BR/>6 hysterectom$.tw. (1969)<BR/>7 exp Ovariectomy/ (210)<BR/>8 Ovariectom$.tw. (75)<BR/>9 oophorectom$.tw. (312)<BR/>10 or/5-6 (2182)<BR/>11 or/7-9 (458)<BR/>12 10 and 11 (175)<BR/>13 4 and 12 (21)<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2014-05-14 12:49:36 +1200" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2014-05-14 12:49:36 +1200" MODIFIED_BY="[Empty name]">PsycINFO search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2010-10-13 15:10:04 +1300" MODIFIED_BY="[Empty name]">
<P>1 premenopaus$.tw. (556)<BR/>2 perimenopaus$.tw. (386)<BR/>3 or/1-2 (866)<BR/>4 exp Hysterectomy/ (336)<BR/>5 hysterectom$.tw. (572)<BR/>6 exp Ovariectomy/ (1112)<BR/>7 ovariectom$.tw. (2626)<BR/>8 oophorectom$.tw. (134)<BR/>9 or/4-5 (592)<BR/>10 or/6-7 (2716)<BR/>11 3 and 9 and 10 (5)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2014-02-26 20:01:42 +1300" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2014-02-26 20:01:42 +1300" MODIFIED_BY="[Empty name]">Cochrane Menstrual Disorders and Subfertility Group Trials Register search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2014-02-26 20:00:09 +1300" MODIFIED_BY="[Empty name]">
<P>"hysterectomised" or "hysterectomized" or "Hysterectomy" or Title CONTAINS "hysterectomised" or "hysterectomized" or "Hysterectomy"</P>
<P>AND</P>
<P>Keywords CONTAINS "oophorectomized women"or"Oophorectomy"or"ovariectomy"or"ovariectomized" or Title CONTAINS "oophorectomized women"or"Oophorectomy"or"ovariectomy"or"ovariectomized"</P>
<P>"hysterectom*" AND "oophorectom*"</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;1 study included in update of the review&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;0 studies included from previous version of the review&lt;/p&gt;" WIDTH="150">
<FLOWCHARTBOX TEXT="&lt;p&gt;1 study that was included in previous version of review was excluded from update of review&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;In previous version of review 1 study included &lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
<FLOWCHARTBOX TEXT="&lt;p&gt;1 study included&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;2 full text articles assessed for eligibility&lt;br&gt; - further information sought on 1 study without published data&lt;/p&gt;" WIDTH="150">
<FLOWCHARTBOX TEXT="&lt;p&gt;251 records screened&lt;/p&gt;" WIDTH="150">
<FLOWCHARTBOX TEXT="&lt;p&gt;For update of review: 251 records identified&lt;/p&gt;" WIDTH="120"/>
<OUT TEXT="&lt;p&gt;249 records excluded&lt;/p&gt;" WIDTH="150"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;1 study excluded as it did not evaluate the intervention of interest in this review&lt;/p&gt;" WIDTH="150"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>